Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
30.96
+0.17
+(0.55%)
As of 8:44:38 AM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 7 | 7 |
| Avg. Estimate | 724.69M | 657.8M | 2.95B | 3.09B |
| Low Estimate | 643.37M | 654M | 2.44B | 2.68B |
| High Estimate | 806M | 661.6M | 3.52B | 3.3B |
| Year Ago Sales | 568M | 537M | 2.26B | 2.95B |
| Sales Growth (year/est) | 27.59% | 22.50% | 30.11% | 4.88% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RPD.F | -- | -- | -- | -- |
| S&P 500 | 16.04% | 7.30% | 10.63% | 14.23% |
Upgrades & Downgrades
| Maintains | Citigroup: Buy to Buy | 10/25/2024 |
| Maintains | Goldman Sachs: Buy to Buy | 8/14/2024 |
| Maintains | Morgan Stanley: Overweight to Overweight | 7/11/2024 |
| Downgrade | UBS: Buy to Neutral | 6/3/2024 |
| Maintains | B of A Securities: Buy to Buy | 4/12/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 2/20/2024 |
Related Tickers
HQ1.MU Oruka Therapeutics Inc. R
9.60
0.00%
5KW.F SkinBioTherapeutics plc
0.2160
-2.70%
5CV.MU CureVac NV
2.8900
+0.35%
AM6.F Amicus Therapeutics, Inc.
8.40
-1.18%
ICY.SG Incyte Corp
64.34
+0.06%
600161.SS TIANTAN BIO
19.88
+0.05%
GON.DU Geron Corp
1.5600
+0.13%
1S9.SG Seres Therapeutics Inc
0.6902
+1.77%
ISI.F Ionis Pharmaceuticals, Inc.
31.00
-0.06%
2H51.DU Ocugen Inc
0.5390
+3.95%